Latest Breaking News On - Promore pharmaview - Page 1 : vimarsana.com

CORRECTION BY SOURCE: Notice of Extraordinary General Meeting in Promore Pharma AB

Notice of Extraordinary General Meeting in Promore Pharma AB

Promore Pharma: Interim Report, January-September 2023

Report from the Extraordinary General Meeting of Promore Pharma AB held on 5 October 2023

Promore Pharma: Interim report January

Report from the Annual General Meeting of Promore Pharma AB held on 27 June 2023

Promore Pharma Reduces Costs and Explores the Conditions for a Reverse Acquisition

Promore Pharma Reports Outcome from Clinical Phase II Study with Ensereptide

STOCKHOLM, SE / ACCESSWIRE / April 20, 2023 / Promore Pharma (STO:PROMO) (FRA:8T0) STOCKHOLM, April 20, 2023 -- Promore Pharma AB today announces that the results from the company's Phase II study PHSU05

Invitation to a Presentation of the Results from Promore Pharma's Clinical Trial PHSU05

STOCKHOLM, SWEDEN / ACCESSWIRE / April 20, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) In the light of the publication of the results from the clinical trial PHSU05, Promore Pharma AB (publ) invites to

Promore Pharma Reaches the Clean File Milestone in its Phase II Clinical Trial with Ensereptide

STOCKHOLM, SWEDEN / ACCESSWIRE / February 27, 2023 / Promore Pharma (STO:PROMO) (FRA:8T0) STOCKHOLM, 27 February, 2023 -- Promore Pharma AB announces today that the Clean File milestone has been achieved